Companies Join Forces to Address Urgently Needed Quality Control of CRISPR Genome-editing
January 21, 2020
SAN DIEGO -- COBO Technologies and Cardea Bio partner to bring solutions to challenges with the precision of Genome editing. The partners have agreed to co-develop and market a portfolio of CRISPR QC products and services for quality control (QC) of CRISPR research, agricultural, and pre-clinical programs. Over the longer-term, the parties aim to develop a [...]
Genomenon’s Mastermind Continues to Outpace Qiagen’s HGMD Genetic Database
January 21, 2020
ANN ARBOR, Mich. -- Genomenon® announced that over 175,000 recently documented genetic variants (DNA mutations) have been added to the Mastermind® Genomic Search Engine in the 4th quarter of 2019, for a cumulative total of more than 5.9 million genetic variants. This number reflects the rapidly accelerating pace of genomic discovery, and stands in stark contrast [...]
Scienta Omicron Acquires Sigma Surface Science
January 20, 2020
Scienta Omicron SPM and the Sigma Surface Science SPM and XPS businesses are merging into one new business unit under the roof of Scienta Omicron. Since its foundation in 2013, Sigma has invested significantly into innovative new lines of SPM and XPS products. These, together with the proven Scienta Omicron product range, will be offered [...]
Lasertec releases OPTELICS HYBRID+ confocal laser scanning microscope
January 20, 2020
Yokohama, Japan – Lasertec Corporation today announced the release of OPTELICS HYBRID+, the latest model of OPTELICS HYBRID series confocal laser scanning microscope that combines two sets of optics – laser confocal and white light confocal – for the pursuit of high performance and multi-functions. OPTELICS HYBRID+ will be presented to ELECTROTEST JAPAN from January [...]
Algentech Granted US Patent For A Key Genome Editing Technology
January 20, 2020
VERSAILLES, France -- ALGENTECH, announces the issuance of a key patent in the field of genome editing by the U.S. Patent Office (U.S. patent number 10457950). The technology claimed by the patent amplifies the effectiveness of gene editing in eukaryotic cells and can be applied in synergy with nucleases, including zinc finger nucleases, TALENs, Crispr-Cas9... Algentech's [...]
Applied Cells Announces Evaluation of Its New MARS Platform at The University of Pennsylvania
January 20, 2020
Under an instrument evaluation agreement, researchers at the University of Pennsylvania will explore utilization of “MARS” platform of Applied Cells to assist in protocol development for areas of advanced cancer diagnosis and cancer treatment. Santa Clara, California - University of Pennsylvania (Penn) and Applied Cells, Inc., a Santa Clara, California based biotechnology company, announced today [...]
January 20, 2020
Genomic Vision (Paris:GV) (FR0011799907 – GV), a biotechnology company developing molecular assays and Artificial Intelligence tools to control quality and safety of genetically modified genomes, today announced that its Molecular Combing technology will be used by the US National Institute of Standards and Technology (NIST) to characterize and quantify intended and unintended genome editing events in [...]
January 20, 2020
SAN DIEGO – SLAS 2020 – Biosero, Inc. will release new Green Button GoTM software products and features, as well as a version that is certified 21 CFR Part 11 compliant, at the 2020 Society for Laboratory Automation and Screening Conference (SLAS 2020) in San Diego, California. “You can have all the data in the world, but if you can’t visualize [...]
DIVESTMENT OF EMS BRÜEL & KJÆR
January 17, 2020
Spectris plc ('Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that, together with Macquarie Corporate Holdings Pty Limited (‘Macquarie’), it has agreed to divest the EMS Brüel & Kjær joint venture ('EMS B&K') to Envirosuite Limited (‘Envirosuite’). Envirosuite is an environmental management technology company and is listed on the Australian Securities Exchange. [...]
CellFE Raises $3.6M in Seed Round Co-led by Cota Capital and Dynamk Capital
January 16, 2020
SAN CARLOS, Calif., Jan. 16, 2020 -- CellFE, Inc., an innovative startup developing a microfluidics based device to deliver gene-editing molecules, today announced it has raised $3.6 million in an initial Series Seed. The oversubscribed round is co-led by Cota Capital and Dynamk Capital, and joined by Embark Ventures. The round is expected to close with additional investors [...]
